| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8925b769d645f9ff06af9f4b189f6a99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
2002-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2c7ee773ba75ba32ab5a03ba07b6ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd163f1716235b9fd4752560017bead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_778e3f534499f83221fb1dd42137b13c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d8527e752416ebbc946912a06e3a08 |
| publicationDate |
2004-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2842735-A1 |
| titleOfInvention |
MODIFIED RELEASE MICROCAPSULES OF LOW SOLUBLE ACTIVE PRINCIPLES FOR PER OS ADMINISTRATION |
| abstract |
The present invention relates to microcapsules allowing the modified release in a reliable and industrially reproducible manner of a principle (AP) which is poorly soluble in water, to the exclusion of antihyperglycemic agents. Each of these microcapsules comprises a core of poorly soluble AP and a coating film applied to the core. Their average diameter is less than 1000 microns. The coating film contains a film-forming polymer (P1) insoluble in the fluids of the gastrointestinal tract; a water-soluble polymer (P2); a plasticizer (PL); and optionally a lubricating surfactant (TA). This coating film represents at least 4% w / w dry of their total mass, and its components P1, P2, PL satisfy the following characteristics: mass fraction by dry weight of P1 relative to the total mass of the coating, between 40 and 90%; mass fraction by dry weight P2 / P1 + P2 between 15 and 60%; mass fraction by dry weight PL / P1 + PL between 1 and 30%. The invention also relates to the applications of said microcapsules in galenics. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125811-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2869764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2886150-A1 |
| priorityDate |
2002-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |